QuidelOrtho (QDEL) Other Non-Current Liabilities (2022 - 2026)
QuidelOrtho (QDEL) posted Other Non-Current Liabilities of $112.4 million for Q1 2026, down 32.45% sequentially from $166.4 million in Q4 2025, and up 61.03% YoY from $69.8 million in Q1 2025.
QuidelOrtho (QDEL) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
QuidelOrtho has reported Other Non-Current Liabilities for 5 years, with the latest figure at $112.4 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 61.03% year-over-year to $112.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112.4 million (up 61.03% YoY) and the FY2025 annual result came in at $166.4 million, up 200.9% from the prior year.
- Other Non-Current Liabilities declined to $112.4 million in Q1 2026 per QDEL's latest filing, from $166.4 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $166.4 million in Q4 2025 and troughed at $48.5 million in Q1 2022.
- A 5-year average of $92.2 million and a median of $83.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities plunged 39.33% in 2024, then jumped 200.9% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $86.6 million in 2022, then slipped by 3.46% to $83.6 million in 2023, then plunged by 33.85% to $55.3 million in 2024, then surged by 200.9% to $166.4 million in 2025, then plunged by 32.45% to $112.4 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $112.4 million, $166.4 million, and $138.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | QuidelOrtho | 992.74 Mn | 869.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 137.00 Mn |
| Mar 29, 2026 | 112.40 Mn |
| Dec 28, 2025 | 166.40 Mn |
| Sep 28, 2025 | 138.70 Mn |
| Jun 29, 2025 | 133.00 Mn |
| Mar 30, 2025 | 69.80 Mn |
| Dec 29, 2024 | 55.30 Mn |
| Sep 29, 2024 | 119.30 Mn |
| Jun 30, 2024 | 70.50 Mn |
| Mar 31, 2024 | 67.40 Mn |
| Dec 31, 2023 | 83.60 Mn |
| Oct 1, 2023 | 65.40 Mn |
| Jul 2, 2023 | 68.50 Mn |
| Apr 2, 2023 | 111.10 Mn |
| Jan 1, 2023 | 83.80 Mn |
| Oct 2, 2022 | 86.60 Mn |
| Jul 3, 2022 | 87.30 Mn |
| Jan 2, 2022 | 48.50 Mn |